541304 — Indo US Bio-Tech Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹4.61bn
- IN₹4.76bn
- IN₹617.45m
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | Interim Report | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 28.1 | 28.6 | 39.3 | 53.1 | 73.9 |
Depreciation | |||||
Non-Cash Items | 4.59 | 9.22 | 11.7 | 12 | 11.9 |
Other Non-Cash Items | |||||
Changes in Working Capital | -66.8 | -47.8 | -52 | -42.5 | -88.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -31.7 | -7.85 | 1.58 | 27 | 5.26 |
Capital Expenditures | -12.9 | -3.96 | -19.5 | -39.7 | -18.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -12.6 | -1.91 | 1.74 | -14.8 | -48.5 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -25.6 | -5.87 | -17.8 | -54.4 | -66.7 |
Financing Cash Flow Items | -3.96 | -8.84 | -11.7 | -11.7 | -11.8 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 57.4 | 14.9 | 15.5 | 26.5 | 62.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.111 | 1.18 | -0.66 | -0.852 | 1.41 |